Janus Henderson Group’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-406,389
| Closed | -$32.4M | – | 1708 |
|
|
2021
Q1 | $32.4M | Sell |
406,389
-732,354
| -64% | -$57.2M | 0.01% | 663 |
|
|
2020
Q4 | $89.8M | Sell |
1,138,743
-3,462
| -0.3% | -$203K | 0.04% | 392 |
|
|
2020
Q3 | $50.2M | Sell |
1,142,205
-9,804
| -0.9% | -$483K | 0.03% | 501 |
|
|
2020
Q2 | $51M | Sell |
1,152,009
-397,646
| -26% | -$14.8M | 0.03% | 486 |
|
|
2020
Q1 | $55.6M | Sell |
1,549,655
-914,635
| -37% | -$52M | 0.04% | 431 |
|
|
2019
Q4 | $175M | Buy |
2,464,290
+598,142
| +32% | +$43.4M | 0.09% | 247 |
|
|
2019
Q3 | $140M | Buy |
1,866,148
+98,481
| +6% | +$8.35M | 0.08% | 281 |
|
|
2019
Q2 | $143M | Buy |
1,767,667
+1,198,169
| +210% | +$84.2M | 0.08% | 285 |
|
|
2019
Q1 | $38.1M | Sell |
569,498
-25,781
| -4% | -$1.95M | 0.02% | 632 |
|
|
2018
Q4 | $44.3M | Sell |
595,279
-14,765
| -2% | -$1.22M | 0.03% | 567 |
|
|
2018
Q3 | $56.2M | Buy |
610,044
+5,717
| +0.9% | +$545K | 0.03% | 559 |
|
|
2018
Q2 | $59.4M | Buy |
604,327
+29,609
| +5% | +$3.31M | 0.03% | 503 |
|
|
2018
Q1 | $64M | Sell |
574,718
-10,324
| -2% | -$1.16M | 0.04% | 492 |
|
|
2017
Q4 | $60.2M | Buy |
585,042
+207,388
| +55% | +$20.7M | 0.04% | 500 |
|
|
2017
Q3 | $35.6M | Sell |
377,654
-103,968
| -22% | -$8.21M | 0.02% | 602 |
|
|
2017
Q2 | $37.5M | Sell |
481,622
-21,316
| -4% | -$1.6M | 0.03% | 589 |
|
|
2017
Q1 | $40.3M | Sell |
502,938
-24,101
| -5% | -$1.92M | 0.28% | 83 |
|
|
2016
Q4 | $41.5M | Sell |
527,039
-148,821
| -22% | -$11.6M | 0.31% | 82 |
|
|
2016
Q3 | $52.7M | Sell |
675,860
-4,156
| -0.6% | -$302K | 0.39% | 59 |
|
|
2016
Q2 | $46.7M | Buy |
680,016
+230,084
| +51% | +$15.9M | 0.39% | 67 |
|
|
2016
Q1 | $32.1M | Sell |
449,932
-13,988
| -3% | -$878K | 0.26% | 107 |
|
|
2015
Q4 | $28.8M | Buy |
463,920
+6,392
| +1% | +$390K | 0.23% | 120 |
|
|
2015
Q3 | $25.9M | Buy |
457,528
+9,467
| +2% | +$501K | 0.23% | 124 |
|
|
2015
Q2 | $24M | Buy |
448,061
+17,054
| +4% | +$830K | 0.19% | 149 |
|
|
2015
Q1 | $26.9M | Sell |
431,007
-17,520
| -4% | -$776K | 0.21% | 135 |
|
|
2014
Q4 | $19.4M | Buy |
+448,527
| New | +$18.3M | 0.14% | 195 |
|
Janus Henderson Group's CMD Position: Q2 2021 in Review
Janus Henderson Group sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 406,389 shares — an estimated $32.4M sold.
Janus Henderson Group first reported a position in CMD in Q4 2014 and held it in 26 quarters. The position peaked at $175M in Q4 2019. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Janus Henderson Group reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Janus Henderson Group sold 406,389 Cantel Medical Corporation shares in Q2 2021, an estimated $32.4M.
- Janus Henderson Group first reported a position in Cantel Medical Corporation in Q4 2014 and held it in 26 quarters.
- Janus Henderson Group's Cantel Medical Corporation position peaked at $175M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Janus Henderson Group's 13F filing for Q2 2021, filed 16 Aug 2021.